{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:51:39Z","timestamp":1787064699230,"version":"build-2736575974"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1093\/cid\/cix154","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T08:46:15Z","timestamp":1487234775000},"page":"1263-1267","source":"Crossref","is-referenced-by-count":70,"title":["Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada"],"prefix":"10.1093","volume":"64","author":[{"given":"Philippe","family":"De Wals","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Deceuninck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston","family":"De Serres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Gilca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodica","family":"Gilca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Boulianne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,16]]},"reference":[{"key":"key\n\t\t\t\t20170418093848_CIT0001","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.15585\/mmwr.mm6441a3","article-title":"Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the advisory committee on immunization practices, 2015","volume":"64","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20170418093848_CIT0002","author":"National Advisory Committee on Immunization","year":"2014"},{"key":"key\n\t\t\t\t20170418093848_CIT0003","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/JCM.00601-06","article-title":"Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19)","volume":"44","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170418093848_CIT0004","doi-asserted-by":"crossref","first-page":"e50659","DOI":"10.1371\/journal.pone.0050659","article-title":"The changing epidemiology of meningococcal disease in Quebec, Canada, 1991\u20132011: potential implications of emergence of new strains","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170418093848_CIT0005","author":"Groupe scientifique en immunisation de l\u2019Institut national de sant\u00e9 publique du Qu\u00e9bec","year":"2015"},{"key":"key\n\t\t\t\t20170418093848_CIT0006","first-page":"40","article-title":"Enhanced surveillance of invasive meningococcal disease in Canada, 2006\u20132011","volume-title":"Can Commun Dis Rep","year":"2014"},{"key":"key\n\t\t\t\t20170418093848_CIT0007","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12866-015-0469-6","article-title":"Characterization of invasive Neisseria meningitidis strains from Qu\u00e9bec, Canada, during a period of increased serogroup B disease, 2009\u20132013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets","volume":"15","year":"2015","journal-title":"BMC Microbiol"},{"key":"key\n\t\t\t\t20170418093848_CIT0008","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.vaccine.2013.03.063","article-title":"Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)","volume":"32","author":"members of the Canadian Immunization Monitoring Program, Active (IMPACT)","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170418093848_CIT0009","author":"Comit\u00e9 sur l\u2019immunisation du Qu\u00e9bec (CIQ)","year":"2014"},{"key":"key\n\t\t\t\t20170418093848_CIT0010","first-page":"1055","article-title":"Field evaluation of vaccine efficacy","volume":"63","year":"1985","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20170418093848_CIT0011","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1542\/peds.2014-4015","article-title":"First use of a serogroup B meningococcal vaccine in the US in response to a university outbreak","volume":"135","year":"2015","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170418093848_CIT0012","unstructured":"Breakwell L. Understanding factors affecting University of California Santa Barbara students\u2019 decision to get vaccinated with Bexsero, an unlicensed meningitides B vaccine: a survey on students\u2019 knowledge, attitudes and practices (poster). In: 19th International Pathogenic Neisseria Conference, Asheville, NC, 12\u201317 October 2014."},{"key":"key\n\t\t\t\t20170418093848_CIT0013","doi-asserted-by":"crossref","first-page":"520","DOI":"10.15585\/mmwr.mm6520a3","article-title":"Notes from the field: outbreak of serogroup B meningococcal disease at a university\u2014California, 2016","volume":"65","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20170418093848_CIT0014","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","article-title":"Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170418093848_CIT0015","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0140-6736(14)60842-4","article-title":"Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial","volume":"384","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170418093848_CIT0016","year":"2016"},{"key":"key\n\t\t\t\t20170418093848_CIT0017","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1016\/j.vaccine.2016.06.025","article-title":"Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: a Canadian immunization research network study","volume":"34","year":"2016","journal-title":"Vaccine"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/64\/9\/1263\/13635241\/cix154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T15:06:06Z","timestamp":1503587166000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cix154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":17,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,2,16]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix154","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]}}}